Related Experiment Video

Updated: Jan 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K

Evaluation of sudden cardiac death in hypertrophic cardiomyopathy

Sang Gon Yoon1, Geu-Ru Hong2

  • 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Journal of Cardiovascular Imaging
|October 16, 2025
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is manageable, but sudden cardiac death remains a risk, especially for young athletes. Ongoing research refines risk assessment and treatment strategies for HCM.

Area of Science:

  • Cardiology
  • Genetics
  • Preventive Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) management has improved, reducing mortality.
  • Sudden cardiac death (SCD) remains a significant, unresolved threat in HCM, particularly in young individuals and athletes.
  • Evolving clinical evidence necessitates updated guidelines for SCD risk stratification in HCM.

Purpose of the Study:

  • To review current research on hypertrophic cardiomyopathy.
  • To explore recent therapeutic advances and their impact on HCM management.
  • To provide insights into future directions for HCM treatment and SCD prevention.

Main Methods:

  • Literature review of recent research findings.
  • Analysis of updated guidelines for SCD risk evaluation in HCM.
  • Synthesis of emerging clinical evidence on risk stratification and management.

Main Results:

  • Therapeutic advances have significantly decreased overall mortality in HCM.
  • Sudden cardiac death (SCD) risk stratification and management in HCM are areas of active research and guideline evolution.
  • New evidence continues to refine understanding of risk factors and effective interventions.

Conclusions:

  • While HCM is increasingly manageable, SCD remains a critical concern requiring ongoing research.
  • Continued investigation into risk stratification and novel therapeutic strategies is essential for improving outcomes in HCM patients.
  • Future research should focus on personalized treatment approaches and enhanced SCD prevention in hypertrophic cardiomyopathy.

Keywords:
EtiologyHypertrophic cardiomyopathyPathophysiologyRisk factorsSudden cardiac death

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.6K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.2K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
464
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
498
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
324
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209